The Rx Recap: August 10-15

Welcome to this week’s roundup of the most insightful and impactful articles from the sister publications of Dermatology Times, all under One MJH Life Sciences. Our network brings together expert perspectives, clinical advancements, and industry updates to keep clinicians informed and ahead of the curve. From cutting-edge treatments to practice management strategies, here’s a look at the top stories shaping the field of medicine.

Top AI models show high accuracy in breast cancer screening

Contemporary OBGYN reports that AI algorithms are showing strong performance in detecting breast cancer on mammograms. In the RSNA AI Challenge, the top algorithms performed near the level of average screening radiologists, achieving high specificity and predictive values. Researchers say these tools could improve cancer detection while keeping recall rates clinically realistic and highlight the value of publicly sharing the algorithms and datasets to advance further research.

Learn How Communication Shapes Pandemic Preparedness—Health Watch USA 2025"

Infection Control Today highlights the critical role of clear communication in pandemics, as emphasized by William Schaffner, MD, professor of medicine at Vanderbilt University. Speaking ahead of his keynote at the Health Watch USA Conference, Schaffner reflected on lessons from COVID-19, noting that inconsistent messaging—particularly around masks—undermined public trust. He stressed that simple, transparent communication, acknowledgment of uncertainties, and building trust are essential for effective public health responses, and reminded clinicians that their role extends beyond care to educating the public.

GLP-1 RAs Prescribed for More Than One-Third of US Adults With Diabetes in Middle Age: NCHS Data Brief

Patient Care reports that GLP-1 receptor agonist (GLP-1 RA) use among US adults with diagnosed diabetes continues to rise, with more than one in four adults (26.5%) reporting use in 2024. Use peaked in adults aged 50–64 years and was higher among Hispanic and Black populations, as well as individuals with obesity or already on other diabetes therapies. The findings, from a National Center for Health Statistics (NCHS) survey, highlight both the growing clinical and economic impact of GLP-1 RAs, while also pointing to disparities in access and prescribing patterns that warrant further attention.

5 Key Takeaways on Medicaid Policy Changes From Savista’s Chief Strategy Officer

AJMC reports that proposed Medicaid reforms under the federal Budget Reconciliation Act could significantly affect patient access and hospital operations. Laxmi Patel, chief strategy officer at Savista, highlighted that new work requirements, reduced retroactive coverage, and stricter documentation may disproportionately impact vulnerable populations, including low-income families, older adults, and immigrants. Hospitals, particularly smaller and rural providers, may face operational and financial strain, prompting the need for proactive strategies such as upgraded IT systems, telehealth programs, and community outreach to maintain access and equity.

Community Pharmacies Are Safe, Accessible Locations for Adolescent Reproductive Health Care

Drug Topics reports that community pharmacies can serve as safe and accessible points of care for adolescents seeking sexual and reproductive health services. A review of 34 studies found that adolescents view pharmacists as knowledgeable and convenient sources for contraception, including emergency contraceptive pills, though concerns about privacy, judgment, and embarrassment remain. Investigators note that pharmacists’ attitudes, comfort with adolescent sexual activity, and need for additional training influence how effectively these services are delivered.

Want to read more on specialty care, pharmacy, industry sciences, and more? Check out MJH Life Sciences full list of brands here.